# Pizarra — PT-pseudo_2fbb84505a45 (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_2fbb84505a45
Task: 1

Encounter: Urology - outpatient on 26 Feb 2025.
Referrer: Dr. K. Bakker (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 63-year-old male
  - PSA: 8.4 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.1 ng/mL²
  - PSA velocity: 2.3 ng/mL/yr
  - Prior PSA: 6.7 ng/mL
  - Prostate volume: 78.0 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.44532543 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 8.4 ng/mL. PI-RADS 4. PSAD 0.10. Prostate volume 78 mL. csPCa 0.45.

Vitals: weight 65 kg, height 176 cm, BMI 21.0, BP 135/64 mmHg, HR 73 bpm. Smoking: Ex-smoker (27 pack-yr, quit 2011).

Chief complaint: Persistent PSA elevation and prior positive prostate biopsy warrant clinical reassessment.

History: A 63-year-old graphic designer, married and residing with his partner, initially presented for evaluation of a PSA elevation detected in early 2024. Lower urinary tract symptoms remain mild, scoring an IPSS of 5 without significant daily disruption. Physical activity continues at a steady pace, featuring two weekly cycling sessions covering roughly 20 kilometres each, alongside complete abstinence from alcohol. Surgical past history includes a resolved childhood appendectomy and a minor arthroscopic knee intervention in 2018. Tobacco use ceased entirely in 2011, following a cumulative 27 pack-year exposure. The patient reports no unexplained weight fluctuations, skeletal discomfort, or haematuria.

Physical examination: DRE — texture: smooth and rubbery; symmetry: intact; nodularity: absent. The prostate demonstrates uniform enlargement. Vital parameters remain stable, recording a blood pressure of 135/64 mmHg and a regular pulse of 73 bpm. Abdominal and cardiovascular assessments yield no abnormalities, while peripheral lymph nodes and bony structures show no tenderness or enlargement.

Patient info: graphic designer; Married; Lives with partner.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Cycling 2x/week, ~20 km; IPSS score: 5/35 (mild LUTS).

Recent other appointments: GP practice nurse — flu vaccination.
Admin: Interpreter: not required. Consent for data use: signed.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: NO BIOPSY
  p(biopsy = yes) = 0.50 +/- 0.19   (95% CI 0.14-0.86)

Where the uncertainty comes from:
  - aleatoric  dA = 0.15  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.12  (few labelled cases resemble this one)
  - 7.4 effective neighbours out of 10; 2 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {no}

TIER 'discuss': A +/- dA straddles 0.5. The classifier genuinely CANNOT tell these two answers apart; measured accuracy in this tier is 0.61, barely above the 0.62 majority-class rate. Its number is a starting point only, and the case must be decided on the clinical evidence retrieved by the other participants.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=4.0, bx_ord=3.0, psa=8.4, age=63.0, psad=0.1, dre_ord=0.0, vol=78.0, n_pmhx=0.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GUIDELINE CRITERION FOR THIS SITUATION

**EXPERT-PROTOCOL** — *protocol expert; applies the guideline criterion for this patient's clinical situation*

CLINICAL SITUATION: prior positive biopsy.

THIS CRITERION RETURNS NO ANSWER FOR THIS PATIENT.

The criterion: The visible panel does NOT determine this decision. The patient already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. The decision must come from the retrieved documents: whether the prior grade is documented, whether the lesion changed against a previous MRI, whether a surveillance re-biopsy is due, and whether treatment is already agreed.

Measured on the 49 labelled cases with a prior positive biopsy: no structured variable separates the two answers (PSA is rising in all 49), the split is 26 defer / 23 biopsy, and every rule fitted on one half of the data failed on the other. This is genuinely undetermined by the panel.

Do not read this as 'defer' and do not read it as 'biopsy'. It means the panel cannot settle the case and the retrieved documents must.

Like the statistical prior, this expert has read ONLY the visible panel. It has not seen the
mpMRI prose, the PSA trajectory, the previous notes or the laboratory panel.

## [4] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
The statistical prior only considered the visible panel data (PI-RADS=4, PSA=8.4, PSA density=0.1, DRE=Normal, Volume=78.0 mL, Prior Biopsy=Positive, csPCa probability=0.445) and failed to incorporate the retrieved documents. Specifically, it did not account for the specific findings from the mpMRI report, the PSA velocity (2.3 ng/mL/yr), or the PSA history trend, which are crucial for assessing disease evolution.

WHY THE SUGGESTION COULD BE WRONG
The prior suggested 'NO BIOPSY' with a wide uncertainty interval (0.50 +/- 0.19). This wide interval suggests the classifier is genuinely unable to distinguish between biopsy and no biopsy based on the limited input. Given the patient has a prior positive biopsy and a rising PSA (from 6.7 to 8.4 ng/mL), the prior's suggestion is potentially wrong because it fails to weigh the clinical urgency implied by the rising PSA velocity and the prior diagnosis. The prior cannot account for the clinical context that mandates re-evaluation.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
radiology report - does the lesion compare with a previous MRI?
PSA history - trend / velocity beyond the headline value
previous GP / urology notes - context regarding the prior positive biopsy
laboratory panel - full panel
previous notes - context regarding the prior positive biopsy

GUIDELINE ANCHOR
The guideline states that the decision must come from retrieved documents: "whether the prior grade is documented, whether the lesion changed against a previous MRI, whether a surveillance re-biopsy is due, and whether treatment is already agreed."

## [5] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
get_mri_report
{"case_id": "PT-pseudo_2fbb84505a45", "radiology_report": "Subject: Multiparametric MRI Prostate | Amsterdam UMC (VUmc) | 15 Feb 2025\nClinical context: Rising PSA (8.4 ng/mL) alongside a previously positive biopsy, raising suspicion for prostate malignancy.\n\nFINDINGS:\nProstatic parenchyma spans 78.0 mL. A distinct hypointense focus occupies the right mid-gland peripheral zone, measuring roughly 12 by 9 mm. Restricted diffusion characterizes this area on DWI, mirrored by attenuated signal on the ADC map. Early focal enhancement appears on dynamic contrast sequences compared to adjacent tissue. Seminal vesicles maintain normal morphology. No evidence of extracapsular extension or suspicious lymph nodes.\n\nIMPRESSION:\n1. PI-RADS 4 lesion situated in the right mid-gland peripheral zone.\n2. Prostate volume 78.0 mL, yielding a PSA density of 0.1 ng/mL/mL.\ncsPCa predicted probability 0.44532543"}
get_psa_trend
{"case_id": "PT-pseudo_2fbb84505a45", "psa_trend": [{"date": "Mar 2024", "val": 2.1}, {"date": "Jul 2024", "val": 3.0}, {"date": "Oct 2024", "val": 2.2}, {"date": "Feb 2025", "val": 8.4}]}
get_previous_notes
{"case_id": "PT-pseudo_2fbb84505a45", "previous_notes": [{"date": "29 Oct 2024", "author": "Dr. K. Bakker (GP)", "text": "The patient underwent clinical review on 29 October 2024 after PSA levels increased to 6.7 ng/mL, a jump from the 4.0 ng/mL recorded in July. A transrectal ultrasound-guided biopsy was subsequently performed, returning a positive result for low-grade adenocarcinoma (Gleason 3+3)."}]}
get_lab_results
{"case_id": "PT-pseudo_2fbb84505a45", "laboratory_results": [{"name": "PSA", "val": "8.4 ng/mL", "date": "18 Jan 2025", "flag": "H"}, {"name": "Free PSA", "val": "1.62 ng/mL", "date": "18 Jan 2025", "flag": ""}, {"name": "%Free PSA", "val": "19%", "date": "18 Jan 2025", "flag": ""}, {"name": "Haemoglobin", "val": "15.9 g/dL", "date": "18 Jan 2025", "flag": ""}, {"name": "WBC", "val": "4.8 x10^9/L", "date": "18 Jan 2025", "flag": ""}, {"name": "Platelets", "val": "214 x10^9/L", "date": "18 Jan 2025", "flag": ""}, {"name": "Creatinine", "val": "85 umol/L", "date": "18 Jan 2025", "flag": ""}, {"name": "eGFR", "val": ">60 mL/min/L/1.73m2", "date": "18 Jan 2025", "flag": ""}, {"name": "Testosterone", "val": "11.6 nmol/L", "date": "18 Jan 2025", "flag": ""}, {"name": "Alkaline phosphatase", "val": "86 U/L", "date": "18 Jan 2025", "flag": ""}, {"name": "LDH", "val": "173 U/L", "date": "18 Jan 2025", "flag": ""}]}
NOT RETRIEVED
The specific ISUP grade group or Gleason score of the prior biopsy result is not explicitly documented in the retrieved notes or lab results.
WHAT THE EVIDENCE SUPPORTS
FOR sampling this patient now:
- PSA velocity of 2.3 ng/mL/yr, indicating a significant rise since the last documented PSA of 6.7 ng/mL.
- mpMRI shows a PI-RADS 4 lesion in the right mid-gland peripheral zone with restricted diffusion and focal enhancement.
- Prior biopsy showed a positive result for low-grade adenocarcinoma (Gleason 3+3).

AGAINST sampling this patient now:
- Prior biopsy result grade (ISUP grade group or Gleason score) is not explicitly documented.
- DRE findings were reported as Normal.

WHERE THIS LEANS
The evidence strongly suggests that a re-evaluation, including a targeted biopsy, is warranted due to the rising PSA velocity and the presence of a PI-RADS 4 lesion on MRI, despite the prior positive biopsy.

[Sections actually revealed in this consultation: radiology_report, psa_trend, previous_notes, laboratory_results. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [6] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [7] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: uncertain)

Although the patient has a prior positive biopsy, the rising PSA velocity of 2.3 ng/mL/yr and the presence of a PI-RADS 4 lesion on MRI necessitate further investigation. The prior biopsy result's ISUP grade or Gleason score is not documented, which means a new biopsy is required to determine the current stage and guide management. The statistical prior suggested no biopsy, but the retrieved evidence of disease evolution and imaging findings strongly supports proceeding with sampling.

Variables that carried weight: bx=important, age=important, dre=noted, psa=decisive, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections revealed: radiology_report, psa_trend, previous_notes, laboratory_results
